Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.
Open | $1.14 |
Close | $1.11 |
Volume / Avg. | 64.46K / 293.20K |
Day Range | 1.10 - 1.16 |
52 Wk Range | 1.05 - 11.06 |
Market Cap | $34.99M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 15.76% |
Days to Cover | 7.67 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immuneering (NASDAQ:IMRX) through any online brokerage.
Other companies in Immuneering’s space includes: Acurx Pharmaceuticals (NASDAQ:ACXP), Gain Therapeutics (NASDAQ:GANX), Curis (NASDAQ:CRIS), Aligos Therapeutics (NASDAQ:ALGS) and Longeveron (NASDAQ:LGVN).
There is no analysis for Immuneering.
Immuneering has a consensus price target of $17.90.
The stock price for Immuneering (NASDAQ: IMRX) is $1.18 last updated July 19, 2024 at 8:42 AM EDT.
There are no upcoming dividends for Immuneering.
Immuneering’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Immuneering.
Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.